Therapeutic Area | MeSH |
---|---|
skin and connective tissue diseases | D017437 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ACANYA | Bausch Health Companies | N-050819 RX | 2008-10-23 | 1 products, RLD, RS |
ONEXTON | Bausch Health Companies | N-050819 RX | 2014-11-24 | 1 products, RLD, RS |
DUAC | Stiefel Laboratories | N-050741 RX | 2002-08-26 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BENZAMYCIN | Bausch Health Companies | N-050557 RX | 1984-10-26 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
EPSOLAY | Mayne Group | N-214510 RX | 2022-04-22 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TWYNEO | Mayne Group | N-214902 RX | 2021-07-26 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CABTREO | Bausch Health Companies | N-216632 RX | 2023-10-20 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
10 acne med | C200263 | 2024-06-05 |
111 medco benzoyl peroxide | C200263 | 2023-12-12 |
2.5 acne med | C200263 | 2024-06-05 |
24 hour acne serum | C200263 | 2025-04-08 |
3 step acne system | OTC monograph final | 2018-02-22 |
30 day acne treatment kit | C200263 | 2024-11-04 |
5 acne med | C200263 | 2024-06-05 |
5 percent benzoyl peroxide cleanser | C200263 | 2023-11-10 |
ab skincare acne spot treatment | OTC monograph final | 2018-09-27 |
acanya | New Drug Application | 2020-09-30 |
Expiration | Code | ||
---|---|---|---|
BENZOYL PEROXIDE, EPSOLAY, GALDERMA LABS LP | |||
2025-04-22 | NP | ||
BENZOYL PEROXIDE / TRETINOIN, TWYNEO, GALDERMA LABS LP | |||
2024-07-26 | NC | ||
BENZOYL PEROXIDE / CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, ENCUBE | |||
2023-03-13 | CGT |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Benzoyl Peroxide, Epsolay, Galderma Labs Lp | |||
11628155 | 2040-12-27 | U-3356 | |
11426378 | 2040-08-18 | U-3356 | |
10933046 | 2040-02-19 | DP | U-3357 |
10945987 | 2040-02-19 | U-3356 | |
11541026 | 2040-02-19 | U-3356 | |
9687465 | 2032-11-27 | DP | U-3356 |
9868103 | 2028-08-08 | DP | U-3194, U-3356 |
Benzoyl Peroxide / Tretinoin, Twyneo, Galderma Labs Lp | |||
10420743 | 2038-07-12 | U-3194 | |
10653899 | 2030-12-30 | DP | U-3194 |
11071878 | 2030-12-30 | DP | |
8617580 | 2028-02-03 | DP | |
Benzoyl Peroxide / Clindamycin Phosphate, Acanya, Bausch | |||
8288434 | 2029-08-05 | DP | U-124, U-134, U-818, U-916, U-921, U-1033 |
8663699 | 2029-06-03 | U-124 | |
8895070 | 2029-06-03 | U-124 | |
9078870 | 2029-06-03 | DP | |
9504704 | 2029-06-03 | DP | U-124, U-134, U-818, U-916 |
9561208 | 2029-06-03 | DP | U-916 |
10137142 | 2029-06-03 | DP | U-916 |
10220049 | 2029-06-03 | DP | U-916 |
10624918 | 2029-06-03 | U-916 | |
Adapalene / Benzoyl Peroxide, Epiduo, Galderma Labs Lp | |||
8071644 | 2027-07-18 | DP | U-1078 |
8080537 | 2027-07-18 | U-1078 | |
8129362 | 2027-07-18 | U-1078 | |
8445543 | 2027-07-12 | U-1078 | |
7820186 | 2025-11-23 | DP | |
7964202 | 2024-09-01 | DP | U-1078 |
Adapalene / Benzoyl Peroxide, Epiduo Forte, Galderma Labs | |||
8703820 | 2023-03-12 | U-1078 | |
8729127 | 2023-03-12 | U-1078 | |
9381179 | 2023-03-12 | U-1078 | |
9387187 | 2023-03-12 | U-1078 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Obesity | D009765 | EFO_0001073 | E66.9 | 7 | 5 | 8 | 13 | 164 | 196 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 13 | 7 | 15 | 17 | 134 | 182 |
Acne vulgaris | D000152 | EFO_0003894 | L70 | 19 | 16 | 40 | 59 | 44 | 172 |
Syndrome | D013577 | — | — | 10 | 35 | 25 | 11 | 96 | 169 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 8 | 4 | 14 | 15 | 84 | 125 |
Stroke | D020521 | EFO_0000712 | I63.9 | 2 | 8 | 12 | 6 | 91 | 117 |
Depression | D003863 | — | F33.9 | 6 | 2 | 6 | 3 | 85 | 102 |
Hypertension | D006973 | EFO_0000537 | I10 | 2 | 7 | 13 | 12 | 68 | 101 |
Cognitive dysfunction | D060825 | — | G31.84 | 3 | 10 | 5 | 7 | 78 | 101 |
Kidney diseases | D007674 | EFO_0003086 | N08 | 3 | 10 | 41 | 11 | 34 | 97 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Exercise | D015444 | EFO_0000483 | — | — | 1 | 2 | — | 95 | 98 |
Covid-19 | D000086382 | — | U07.1 | — | 10 | 9 | — | 46 | 64 |
Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 2 | — | 1 | — | 39 | 42 |
Anxiety | D001007 | EFO_0005230 | F41.1 | 3 | 2 | 1 | — | 36 | 41 |
Obstructive lung diseases | D008173 | — | — | — | 4 | 2 | — | 31 | 37 |
Sleep initiation and maintenance disorders | D007319 | — | F51.01 | 2 | 2 | 3 | — | 28 | 35 |
Inflammation | D007249 | MP_0001845 | — | 3 | 5 | 2 | — | 25 | 32 |
Premature birth | D047928 | EFO_0003917 | O60 | 1 | 2 | 1 | — | 29 | 32 |
Sarcopenia | D055948 | EFO_1000653 | M62.84 | — | — | 1 | — | 30 | 31 |
Carcinoma | D002277 | — | C80.0 | 1 | 15 | 2 | — | 14 | 30 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Aging | D000375 | GO_0007568 | R41.81 | 3 | 3 | — | — | 44 | 50 |
Parkinson disease | D010300 | EFO_0002508 | G20 | 2 | 2 | — | — | 36 | 40 |
Neck pain | D019547 | — | M54.2 | — | 1 | — | — | 36 | 37 |
Prediabetic state | D011236 | EFO_1001121 | R73.03 | 3 | 2 | — | — | 28 | 33 |
Substance-related disorders | D019966 | EFO_0003890 | F13 | 4 | 4 | — | — | 20 | 27 |
Sleep wake disorders | D012893 | — | G47 | 3 | 1 | — | — | 19 | 23 |
Chronic disease | D002908 | — | — | — | 1 | — | — | 21 | 22 |
Pediatric obesity | D063766 | — | — | — | 1 | — | — | 21 | 22 |
Dental caries | D003731 | EFO_0003819 | K02 | — | 1 | — | — | 18 | 19 |
Autistic disorder | D001321 | EFO_0003758 | F84.0 | 2 | 1 | — | — | 15 | 18 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cerebral palsy | D002547 | — | G80 | 3 | — | — | — | 27 | 30 |
Sleep | D012890 | GO_0030431 | — | 4 | — | — | — | 20 | 24 |
Mental health | D008603 | EFO_0003935 | — | 1 | — | — | — | 10 | 11 |
Healthy diet | D000072001 | — | — | 1 | — | — | — | 10 | 11 |
Pain management | D059408 | — | — | 2 | — | — | — | 8 | 10 |
Problem behavior | D000066553 | — | — | 1 | — | — | — | 9 | 10 |
Laparoscopic cholecystectomy | D017081 | — | — | 2 | — | — | — | 7 | 9 |
Oxygen inhalation therapy | D010102 | — | — | 1 | — | — | — | 8 | 9 |
Respiration disorders | D012120 | — | J00-J99 | 1 | — | — | — | 7 | 8 |
Bronchopulmonary dysplasia | D001997 | — | P27.8 | 1 | — | — | — | 6 | 7 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sedentary behavior | D057185 | — | — | — | — | — | — | 52 | 52 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | — | 41 | 41 |
Chronic pain | D059350 | — | — | — | — | — | — | 27 | 27 |
Emergencies | D004630 | — | — | — | — | — | — | 20 | 20 |
Health behavior | D015438 | — | — | — | — | — | — | 20 | 20 |
Weight gain | D015430 | — | — | — | — | — | — | 15 | 15 |
Psychological stress | D013315 | — | — | — | — | — | — | 15 | 15 |
Scoliosis | D012600 | EFO_0004273 | M41 | — | — | — | — | 14 | 14 |
Disease progression | D018450 | — | — | — | — | — | — | 13 | 13 |
Feeding behavior | D005247 | — | — | — | — | — | — | 13 | 13 |
Drug common name | Benzoyl peroxide |
INN | — |
Description | Benzoyl peroxide is a carbonyl compound. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=C(OOC(=O)c1ccccc1)c1ccccc1 |
PDB | — |
CAS-ID | 94-36-0 |
RxCUI | — |
ChEMBL ID | CHEMBL1200370 |
ChEBI ID | 82405 |
PubChem CID | 7187 |
DrugBank | DB09096 |
UNII ID | — |